Skip to main content
. 2021 Dec 6;13(12):2097. doi: 10.3390/pharmaceutics13122097

Table 1.

Particle properties of the LNPs in Figure 2.

Helper PEG Content Size (nm) 1 PdI 1 Zeta Potential (mV)1 mRNA Encapsulation (%) 2
DOPC 0.375% 110.4 ± 8.7 0.15 ± 0.02 −7.16 ± 0.59 73.9 ± 1.6
0.75% 66.5 ± 5.4 0.10 ± 0.01 −4.47 ± 0.21 84.0 ± 1.0
1.5% 46.1 ± 4.7 0.08 ± 0.03 −3.15 ± 0.21 85.4 ± 1.1
3% 36.1 ± 5.1 0.12 ± 0.06 −2.09 ± 0.44 84.7 ± 1.2
POPE 0.375% 106.0 ± 3.6 0.15 ± 0.00 −8.3 ± 0.67 79.0 ± 0.7
0.75% 63.2 ± 4.3 0.12 ± 0.01 −5.9 ± 0.49 85.8 ± 2.1
1.5% 45.5 ± 0.6 0.08 ± 0.00 −4.7 ± 0.53 85.6 ± 2.8
3% 38.9 ± 2.8 0.11 ± 0.01 −2.7 ± 0.57 83.9 ± 1.3

1 Size, PdI, and Zeta potential were evaluated by dynamic light scattering. 2 mRNA encapsulation was evaluated by RibogreenTM assay.